Jorge E. Cortes, MD

Meet Our Director

Dr. Jorge Cortes received his medical degree from the Universidad Nacional Autonoma de Mexico, Mexico City. In September 2019, he joined Augusta University as the Director of the Georgia Cancer Center in Augusta, Georgia, after being at The University of Texas MD Anderson Cancer Center for 27 years, where he was Professor of Medicine and Internist and had many roles in the Department of Leukemia and the Division of Cancer Medicine, including Deputy Department Chair, Chair of AML and CML Sections, Deputy Division Chair for MDACC Network.

He was chair of the executive IRB from 2012 to 2019, and Chair of the Executive Committee of the Medical Staff from 2012 to 2015. He held the Jane & John Justin Distinguished Chair in Leukemia Research at MDACC from 2015 to 2019. He now holds the Cecil F. Whitaker Jr., GRA Eminent Scholar Chair in Cancer endowment.

As Director, Dr. Cortes continues the Georgia Cancer Center’s mission of obtaining National Cancer Institute (NCI) designation, while keeping the mission of ‘reducing the burden of cancer in the State of Georgia and across the globe through superior care, innovation and education’ at the forefront of all endeavors. He has over 230 grants and contracts where he was principal investigator and has led the approval of 4 drugs currently available for patients with leukemia. Dr. Cortes has authored more than 1,000 peer-review original research manuscripts with numerous other accolades towards his name and practice. Dr. Cortes is a member of the National Academy of Medicine in Mexico and he has received numerous awards including the Service to Mankind Award, The Leukemia & Lymphoma Society in 2007, The Otis W. & Pearl L. Walters Faculty Achievement Award in Clinical Research, MDACC, in 2007, the William Randolph Hearst Foundations Faculty Achievement Award in Education, MDACC, in 2013, Samuel J. Hassenbush III, M.D., Ph.D., Physicians Referral Service Leadership and Institutional Service Award at MD Anderson in 2018, the John Goldman Prize from the International CML Foundation in 2018, and Castle Connolly America’s Top Doctor in 2013, 2020 and 2021. He was listed in "A list of highly influential biomedical researchers, 1996-2011" by Boyack et al. Eur J Clin Invest, 2013, and named among the listing of Highly Cited Researchers in 2014 by Thomson Reuters. Dr Cortes has served as Associate Editor for Blood and serves on the editorial board of multiple medical journals; he is currently a member of the Journals Committee of the American Society of Hematology. Dr Cortes is a member of the Board of Directors of the International Chronic Myeloid Leukemia Foundation, President of the Latin American Leukemia Net, member of the National CML Society Medical Advisory Board, member of the International Steering Committee of the Japanese Society of Medical Oncology, and serves on the Augusta University Faculty Development Committee. He has previously served in the National Board of Directors of the Leukemia & Lymphoma Society. He is a graduate of the 2021 Class of Leadership Augusta Executive Forum and serves on the Boards of the Augusta Symphony and Greater Augusta Arts Council.


Deputy Director

photo of Dr. David Munn

Dr. David Munn

  • Deputy Director, GCC

(706) 721-7141

Associate Directors

photo of Anand P. Jillella, MD

Anand P. Jillella, MD

  • Associate Director, Clinical Operations


photo of Balveen Kaur, PhD

Balveen Kaur, PhD

  • Associate Director, Basic Science Research


photo of Sharad Ghamande, MD

Sharad Ghamande, MD

  • Associate Director, Clinical Research


photo of Klaus Ley, MD

Klaus Ley, MD

  • Associate Director, Shared Resources

Administrative Leadership

photo of Al Dallas

Al Dallas

  • Administrator, Chief of Staff


photo of Barbara McFarland

Barbara McFarland

  • Administrator, Outpatient Cancer Services


Reducing the Burden

The Georgia Cancer Center at Augusta University is dedicated to reducing the burden of cancer in Georgia and across the globe through superior care, innovation, and education. Through unprecedented expansion, the Georgia Cancer Center is providing access to more first-in-the-nation clinical trials, world-renowned experts and life-saving options.